Cervical lymph node metastases of medullary thyroid carcinoma: CT findings

European Radiology

Volumn 7, Issue 1, 1997, Pages 99-101

  Pombo, F ^a   Rodriguez E ^a   Cao, J I ^a   Martinez Isla C ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Computed tomography; Diseases; Lymph nodes; Neoplasms; Thyroid

Indexed keywords

AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MEDULLARY CARCINOMA; MIDDLE AGED; NECK; PATHOLOGY; RADIOGRAPHY; THYROID TUMOR; TUMOR RECURRENCE;

AGED; CARCINOMA, MEDULLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NECK; NEOPLASM RECURRENCE, LOCAL; THYROID NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030636270     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300050118     Document Type: Article

References (21)

1. Saad MF, Ordonez NG, Rashid RK et al. (1984) Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Medicine 63: 319-342
2. McCook TA, Putman CE, Dale JK et al. (1982) Medullary carcinoma of the thyroid: radiographic features of a unique tumor. AJR 139: 149-155
3. Dodd GD (1985) The radiologic features of multiple endocrine neoplasia types IIA and IIB. Semin Roentgenol 20: 64-90
4. Schwerk WB, Grün R, Wahl R (1985) Ultrasound diagnosis of C-cell carcinoma of the thyroid. Cancer 55: 624-630
5. Gorman B, Charboneau JW, James EM et al. (1987) Medullary thyroid carcinoma: role of high-resolution US. Radiology 162: 147-150
6. Dörr U, Würstlin S, Frank-Raue K et al. (1993) Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: A comparative study. Horm Metab Res Suppl 27: 48-55
7. Heron CW, Ponder BAJ, Hunter-Craig ID (1990) CT scanning as an adjunct to screening for medullary carcinoma of the thyroid. Clin Radiol 41: 209-210 ,
8. Som PM, Brandwein M, Lidow M et al. (1994) The varied presentations of papillary thyroid carcinoma cervical nodal disease: CTand MR findings. AJNR 15: 1123-1128
9. Naidich DP, Zerhouni EA, Siegelman SS (1991) Mediastinum. In: Naidich DP, Zerouni EA, Siegelman SS (eds) Computed tomography and magnetic resonance of the thorax, 2nd edn. Raven Press, New York, pp 35-148
10. Shapeero LG, Blank N, Young SW (1983) Contrast enhancement in mediastinal and cervical lymph nodes. J Comput Assist Tomogr 7: 242-244
11. Husband JE, Robinson L, Thomas G (1992) Contrast enhancing lymph nodes in bladder cancer: a potential pitfall on CT. Clin Radiol 45: 395-398
12. Locksmith JP, Brannon MH (1991) Diffuse CT contrast enhancement of cervical lymph nodes in angioimmunoblastic lymphadenopathy. Clinical Image. J Comput Assist Tomogr 15: 703-704
13. Koslin DB, Berland LL, Sekar BC (1986) Cervical Castleman disease: CT study with angiographic correlation. Radiology 160: 213-214
14. Herts BR, Megibow AJ, Birnbaum B A et al. (1992) High-attenuation lymphadenopathy in AIDS patients: significance of findings at CT. Radiology 185: 777-781
15. Pombo F, Rodríguez E, Mato J et al. (1992) Patterns of contrast enhancement of tuberculous lymph nodes demonstrated by computed tomography. Clin Radiol 46: 13-17
16. Pombo F, Rodríguez E, Caruncho M et al. (1994) CT attenuation values and enhancing characteristics of thoracoabdominal lymphomatous adenopathies. J Comput Assist Tomogr 18: 59-62
17. Pombo F, Rodríguez E, Aguilera C et al. (1995) CT attenuation values and patterns of enhancement of mediastinal adenopathies in sarcoidosis. Eur Radiol 5 (Suppl): 344
18. Fulcher AS (1993) Cervical lymphadenopathy due to Kikuchi disease: US and CT appearance. J Comput Assist Tomogr 17: 131-133
19. Som PM, Biller HF (1992) Kimura disease involving parotid gland and cervical nodes: CT and MR findings. J Comput Assist Tomogr 16: 320-322
20. Magnussön A, Anderssön T, Larsson B et al. (1989) Contrast enhancement of pathologic lymph nodes demonstrated by computed tomography. Acta Radiol 30: 307-310
21. Young SW, Turner RJ, Castellino RA (1980) A strategy for the contrast enhancement of malignant tumors using dynamic computed tomography and intravascular pharmacokinetics. Radiology 137: 137-147